Disease Identification Articles & Analysis
13 news found
Researchers have long recognized the importance of CCM in regulating cellular function and contributing to the understanding of various diseases, including cancer, diabetes, and neurodegenerative disorders. ...
Additionally, Iso-Seq technology aids in the identification of novel exons, introns, and splicing variants, shedding light on gene structure and functionality. ...
Based on rich experience in genomic analysis, CD Genomics has developed a specialized platform for targeted sequencing of cancer-related genes to accelerate research on disease pathogenesis, disease identification, biomarker discovery, targeted drug development, etc. ...
This first-of-its-kind sequencing process, which provides an unparalleled understanding of proteins, will advance drug discovery and diagnostics and bring transformative health and disease insights to the world. Founded by world-renowned scientist, entrepreneur, and National Medal of Technology and Innovation recipient Dr. Jonathan Rothberg, Quantum-Si developed its ...
About CENTOGENE CENTOGENE engages in diagnosis and research around rare diseases transforming real-world clinical, genetic, and multiomic data to diagnose, understand, and treat rare diseases. Our goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using our extensive rare disease ...
Recently, the company announced the launch of biomarker and target discovery service for disease identification, early diagnosis and prevention, and monitoring during treatment. With the development of high-throughput sequencing technology, new biomarkers can not only be used as indicators for disease diagnosis and later judgment, but also as ...
“Enzyme conjugation is a rapidly growing business in medical diagnostics, gene expression analysis, infectious disease detection, and biological warfare agent identification, among other applications. ...
The product manager has recently announced the fully-developed exosomes lipidomics service to help identify lipid-based biomarkers and unravel its monitoring function in diseases. Exosomes are considered to be a new and effective intercellular communication carrier. ...
SAGA’s platform technologies, which are based on digital PCR and next-generation sequencing, are tools to be used in cancer patient stratification, therapy response monitoring, disease relapse identification, as well as in aiding in treatment decisions and as companion diagnostics. ...
Whereas MH Guide/BRCA detects variants in HBOC-associated genes, MH Guide/Mendel can analyze large gene panels as well as whole- exome or whole-genome data, so that many different hereditary diseases can be identified at once. “With this collaboration in place, Japanese patients will benefit from state-of-the-art genetic identification of inherited ...
Greenberg, MD, identifies biological components of autoimmune disease and immunological response to cancer through bioinformatics and clinical disease observation. These insights lead to identification of novel drug targets expressed by discrete subpopulations of the immune system that can be modulated for therapeutic uses. ...
” This effort leads to better selection of disease targets and identification of patient populations that demonstrate improved clinical outcomes. ...
About 250,000 Australians currently have Alzheimer’s disease, but numbers are anticipated to rise to 1.3 million in the next 40 years if there were not significant breakthroughs in prevention and treatment of the disease. ...